A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

NCT00966004 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1139

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: YM178
DRUG: Placebo
DRUG: tolterodine

Sponsor

Astellas Pharma Inc